Products for Research Use Only
RegisterLogin

Enfortumab vedotin-ejfv

CAT: 0931-T78065-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T78065-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1346452-25-2
Target
Nectin-4, Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related, Immunology/Inflammation
Purity
1
Bioactivity
Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T77405-01Enfortumab
T9901A-044-01Ladiratuzumab vedotin
T9901A-031-01Ozuriftamab vedotin
T81133-01Sofituzumab vedotin
T39595-01Disitamab vedotin
T77838-01Telisotuzumab vedotin
T77186-01Zilovertamab vedotin
T9901A-052-01Vandortuzumab vedotin
T9901A-025-01Lifastuzumab vedotin
T77881-01Tisotumab vedotin

Alternative Products

CatalogName
HY-P99016A-01Enfortumab vedotin-ejfv
HY-P99016B-01Enfortumab vedotin-ejfv (solution)
GTR18398554-01Enfortumab vedotin-ejfv Antibody
MBS1581671-01Enfortumab vedotin-ejfv (ADC)
F1132-50Anti-Nectin-4 Antibody (Enfortumab vedotin-ejfv)
GTR18315698Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)
BIO0863SM-1mgAnti-human Nectin-4 (Enfortumab vedotin-ejfv Biosimilar)
M07964Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)
591830Enfortumab Vedotin (PVRL4)
KBI1302KRIBIOLISA™ Enfortumab Vedotin (PADCEV) ELISA

Popular Products